Erythropoietin-Modified Mesenchymal Stem Cells Enhance Anti-fibrosis Efficacy in Mouse Liver Fibrosis Model

BACKGROUND: Mesenchymal stem cell (MSC)-based cell transplantation is an effective means of treating chronic liver injury, fibrosis and end-stage liver disease. However, extensive studies have found that only a small number of transplanted cells migrate to the site of injury or lesion, and repair ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xianyao, Wang, Huizhen, Lu, Junhou, Feng, Zhanhui, Liu, Zhongshan, Song, Hailiang, Wang, Heng, Zhou, Yanhua, Xu, Jianwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333789/
https://www.ncbi.nlm.nih.gov/pubmed/32621283
http://dx.doi.org/10.1007/s13770-020-00276-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333789/
https://www.ncbi.nlm.nih.gov/pubmed/32621283
http://dx.doi.org/10.1007/s13770-020-00276-2

Ejemplares similares